companydata.dkcompanydata.dk

BIOCHEMFUSION HOLDING ApS: Financial statements 2022

CVR: 35398953

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

BIOCHEMFUSION HOLDING ApS (CVR 35398953) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 20,606 and a net result of DKK 159,194 compared with DKK 178,348 the year before. That is a decrease of 54.4% compared with the year before. The profit margin was 772.6%. Equity in the 2022 report amounted to DKK 454,849. The solvency ratio was 99.9%.

Revenue
DKK 20,606
Gross Profit
DKK 14,088
Profit/Loss
DKK 159,194
Equity
DKK 454,849
Total Assets
DKK 455,126
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
202221 t.14 t.159 t.455 t.0
202145 t.39 t.178 t.446 t.0
2020-842450 t.567 t.0
2019-43 t.633 t.717 t.0
2018-12 t.446 t.634 t.0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on BIOCHEMFUSION HOLDING ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

BIOCHEMFUSION HOLDING ApS: The 2021 annual report is outJun 28, 2022

BIOCHEMFUSION HOLDING ApS has published its annual report for 2021. Revenue came to DKK 45,229, and the net result was DKK 178,348.

About BIOCHEMFUSION HOLDING ApS

BIOCHEMFUSION HOLDING ApS is a Danish company of the type Anpartsselskab based in Ølsted, founded in 2013. The company is registered under the industry Finansielle holdingselskaber. The management consists of Jan Holst Jensen. The company is owned by JAN HOLST HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported revenue of DKK 28,888 and a net result of DKK 16,110 compared with DKK 93,935 the year before. Equity in the 2025 report amounted to DKK 226,586.

Source: annual report 2025, Danish Business Authority